225-543-2 | Sigma-Aldrich

Quality Control Range Sheet- HAGG1-113 and HAGG1-213

mL Control 2 2246 – 4664 pg/mL Control 2 543– 1128 pg/mL Endothelin-1 Control 1 67 – 140 pg/mL VEGF-D Control 1 133 – 277

Quality Control Ranges: MILLIPLEX® MAP Human Cytokine/ Chemokine Magnetic Bead Panel

Control 1 109 – 225 pg/mL Control 2 542 – 1126 pg/mL Control 2 543 – 1128 pg/mL IL-15 Control 1

XP725 Antibody Number-Lot Number 071M4826

491 492 513 514 515 516 537 538 539 540 561 562 563 564 6.4 493 494 495 496 517 518 519 520 541 542 543 544 565 566 567 568 6.5 497 498 499 500 521 522 523 524 545 546

Examination of Non-Specifically Bound Proteins and Peptides Following Depletion of Twenty High Abundance Proteins from Human Plasma

precursor 393 8 131 3 551 11 193 6 571 11 543 11 67 1 194 5 828 14 1051 19 IPI00022432 Transthyretin precursor 47 1 138 3 74 1 59 1 59 1 86 2 66 1 71

An Update on Ligands for Prostanoid Receptors

479-500 (1993). 74. Armstrong, R.A., et al., Br. J. Pharmacol., 87, 543-551 (1986). 75. Seiler, S, et al., J. Pharmacol. Exp. Ther., 225, 1021-1026 (1990). 76. Hamanaka, N., et al., Bioorg. Med. Chem. Lett

Nitrate Spectroquant Test Kits Equivalency Report 2017

Volume of Stock Standard Diluted to 100 mL Final Standard Concentration 1 2 45 225 2 40 200 2 30 150 2 25 125 3 100 100 3 75 75 3 50 50 3

Cytoskeletal Signaling Antibodies, Reagents and Kits

conjugate KA 1 mg 12-543 Tyrosine Kinase (Src Family) Substrate Peptide Pack KA 1 kit 17-111 Src Substrate Peptide KA 1 mg 12-140 Src Substrate Peptide, biotin conjugate KA 1 mg 12-543 siRNA Src

XP725 Antibody List Lot 129K4830

phospho-p53 (pSer392) P8982 7157 TP53 P NP_000537.3 ,NP_001119584.1 ,NP_001119585.1 , NP_001119586.1 y y n/d 543 p53 BP1 B4561 7158 TP53BP1 P NP_001135451.1 y n/d n/d 544 p53 BP1 B4436 7158 TP53BP1 P NP_001135451.1

XP725 Antibody List Lot 129K4831

phospho-p53 (pSer392) P8982 7157 TP53 P NP_000537.3 ,NP_001119584.1 ,NP_001119585.1 , NP_001119586.1 y y n/d 543 p53 BP1 B4561 7158 TP53BP1 P NP_001135451.1 y n/d n/d 544 p53 BP1 B4436 7158 TP53BP1 P NP_001135451.1

XP725 Antibody List Lot 089K4791

phospho-p53 (pSer392) P8982 7157 TP53 P NP_000537.3 ,NP_001119584.1 ,NP_001119585.1 , NP_001119586.1 y y n/d 543 p53 BP1 B4561 7158 TP53BP1 P NP_001135451.1 y n/d n/d 544 p53 BP1 B4436 7158 TP53BP1 P NP_001135451.1

Nutrition Research

2R,3R)-3,3’,4’,5,7-Pentahydroxyflavanone C15H12O7 FW 304.25 [480-18-2] BRN 5299277 BioChemika, ;85% (HPLC) EC No. 207-543-4 RTECS # LK6920000 78666-25MG-F 25 mg 78666-100MG-F 100 mg

Bioreactor Systems for Bone Tissue Engineering

direction. Biomed Mater 2, 174, 2007. 115. Buckley, M.J., et al. Osteoblasts increase their rate of divi- sion and align in response to cyclic, mechanical tension in vitro. Bone Miner 4, 225, 1988. 116. Chamay

MAPK: Antibodies, Proteins, Kits, siRNA and Reagents

IgG 200 µg 36-013 Protein MKK7α1, active KA APur 25 µg 14-301 MKK7β1, active KA 10 µg 14-543 MKK7β1, unactive KA 50 µg 14-542 siRNA MKK7 siRNA/siA Assay Kit H WB RNAi 1 kit

List of Antibodies

540 phospho-p53 (pSer392) P8982 P y y n/d 541 p53DINP1/SIP P4868 P y y y 542 p53R2l P4993 P y y y 543 p53 BP1 B4561 P y y y 544 p53 BP1 B4436 P y y n/d 545 p57kip2 P2735

XP725 Antibody List

P4993 299976, 50484, 382985 Rrm2b,RRM2B,Rrm2b_predicted XP_235367.4,NP_056528.2,NP_955770.1 P y y y 543 p53 BP1 B4561 27223, 7158, 296099 TP53BP1,Trp53bp1_predicted,Trp53bp1 NP_038763.3,NP_005648.1,NP_001099971.1

XP725 Antibody List 013M4793

P4993 299976, 50484, 382985 Rrm2b,RRM2B,Rrm2b_predicted XP_235367.4,NP_056528.2,NP_955770.1 P y y y 543 p53 BP1 B4561 27223, 7158, 296099 TP53BP1,Trp53bp1_predicted,Trp53bp1 NP_038763.3,NP_005648.1,NP_001099971.1

Halal Certificate

DECEN-2-ONE PREDOMINANTLY TRANS, 97% W353205 A65269 HC-23SIGW82 225. 3-ETHYL-2-HYDROXY-2-CYCLOPENTEN-1-ONE SOLUTION 50 WT. % IN PROPYLENE GLYCOL W315214 B60245 HC-23SIKR58 226. 3-ETHYL-2-HYDROXY

Halal Certificate

DECEN-2-ONE PREDOMINANTLY TRANS, 97% W353205 A65269 HC-22SI5404 225. 3-ETHYL-2-HYDROXY-2-CYCLOPENTEN-1-ONE SOLUTION 50 WT. % IN PROPYLENE GLYCOL W315214 B60245 HC-22SID779 226. 3-ETHYL-2-HYDROXY

XP725 Worksheet for Lot Number 071M4826

F5303 537 3 4 2 1 Fas CD95 Apo1 F4424 538 3 4 2 2 Fas CD95 Apo1 F4424 539 3 4 2 3 Fas Ligand F2051 540 3 4 2 4 Fas Ligand F2051 541 3 4 2 5 Fas Ligand F1926 542 3 4